We are a Specialty Pharmaceutical Company with a Focus in Pain and Addiction

BEMA® Technology

A small, dissolvable polymer film for application to mucosal membranes (inner lining of cheek) which allows for transmucosal delivery of drugs.

 

Dr. Mark A. sirgo, president & ceo

 to present at

26th annual piper jaffray healthcare conference

wednesday, december 3, 2014 at 10:30 a.m. ET

click here for the audio webcast

_____________________________________________

jefferies 2014 global healthcare conference

november 20, 2014 at 1:00 pm GMT (8:00 am est)

click here for webcast

_______________________________________________

stifel 2014 healthcare conference

tuesday, november 18, 2014 at

9:45 a.m. ET

click here for webcast

_______________________________________________

credit suisse 2014 Healthcare conference

wednesday, november 12, 2014 at

11:30 a.m. mst (1:30 p.m. est)

click here for webcast

_________________________________________

BUNAVAIL Launch update - conference call and webcast

Tuesday, october 7 at 8:00 a.m.

CLICK HERE FOR WEBCAST

 _________________________________________________________________

 

BDSI INVESTOR & ANALYST UPDATE

FRIDAY, SEPTEMBER 5, 2014

12:00 TO 2:00 P.M. ET

 

CLICK HERE FOR THE REPLAY OF WEBCAST 

 

Get the latest details on our products and services.

Top News

BioDelivery Sciences Launches InReach Support Program for Those Affected by Opioid Dependence
Website and Mobile App Offer Comprehensive Array of Information and Resources to Support Patients and Their Families


BioDelivery Sciences Announces Completion of Randomization in Phase 3 Trial of Clonidine Topical Gel for the Treatment of Painful Diabetic Neuropathy
Top line data anticipated by end of first quarter 2015